| Comment | 0.345 | Jean-Francois Tardif | Very risky. Working on projects where the potential is substantial. Doesn’t always happen as the market hopes for. | 2008-07-15 | |
| BUY | 0.390 | Peter Imhof | Have a red blood cell booster for people who are going into chemotherapy. Have signed a couple of deals but he is really waiting for a joint venture. A “show me” stock. Good risk/reward. | 2008-06-18 | |
| BUY | 0.385 | Serge Depatie | The cat with 9 lives. Started off as a technology company to process biotechnology products. This is doing fine and will be a good business for them eventually. Have just disclosed phase 2 results for an immune drug that will compete with Amgen products. FDA almost took Amgen products off but there was no alternative. Now this company is coming in that could replace the therapy. On his radar screen. | 2008-05-07 | |
| BUY | 0.480 | Chyanne Fickes | Has a technology for filtering blood. Just received European approval in the latter part of 06. Will be launching in the 2nd half of this year. Expecting them to be making money next year. | 2007-04-17 | |
Experts that have talked about Prometic Life Sciences Inc.
Rss Top Picks Feed
